Skip to content

OBBB: Trump jeopardizes 1.2 million healthcare jobs

  • News

Washington, June 28, 2025 – The U.S. House of Representatives passed the controversial “One Big Beautiful Bill Act” on May 22, 2025, a budget bill that includes massive cuts to the social programs Medicaid and the Supplemental Nutrition Assistance Program (SNAP). According to a new analysis by the Commonwealth Fund and the George Washington University Milken Institute School of Public Health, these cuts could lead to a loss of 1.22 million jobs, a decrease in state gross domestic product (GDP) of $154 billion, and a loss of $12 billion in state and local tax revenue by 2029. The economic damage would significantly exceed the planned federal savings of $131 billion, particularly in poorer states. Cuts in focus: Medicaid and SNAP The bill proposes cuts of $863 billion to Medicaid and $295 billion to SNAP over a ten-year period (2025–2034). According to estimates… 

more »OBBB: Trump jeopardizes 1.2 million healthcare jobs

FDA warns of Medtronic Bravo CF capsules due to serious health risks

Washington, June 28, 2025 – The U.S. Food and Drug Administration (FDA) has issued an urgent warning as part of its pilot communication program to improve medical device recall processes. Certain lots of Medtronic's Bravo CF capsule delivery systems and its subsidiary Given Imaging Inc. are affected, which are used for esophageal pH monitoring. Due to a manufacturing defect, the capsules may not attach to the esophagus as intended or may not detach correctly from the delivery system, posing serious health risks. The Bravo CF capsule is placed in the esophagus to record pH data and help physicians diagnose gastroesophageal reflux disease. The capsule transmits data to a recorder attached to the patient's belt, allowing symptoms to be correlated with reflux episodes. Medtronic has requested affected customers on June 3, 2025, and in an updated notice on June 16, 2025, to return the affected...

more »FDA warns of Medtronic Bravo CF capsules due to serious health risks

FDA imposes import ban on certain Olympus medical devices from Japan

  • News

Washington, June 28, 2025 – The U.S. Food and Drug Administration (FDA) has imposed an import ban on certain medical devices from Olympus Medical Systems Corporation and its subsidiaries manufactured in Japan. The reason is persistent violations of quality regulations that have not been rectified despite the company's comprehensive efforts. The measure affects 58 models of medical devices, including ureterorenoscopes, bronchoscopes, laparoscopes, and automated endoscope reprocessors, primarily manufactured at the Aizu production site in Japan. The FDA has issued Import Alerts (Import Alert 89-04) to prevent future shipments of these devices to the U.S. Following inspections in 2022 and 2023, the agency had already sent warning letters to Olympus multiple times, citing violations of current good manufacturing practices (CGMP) and reporting requirements, particularly for serious recalls. "Despite intensive and ongoing efforts to address the compliance issues, the FDA continues to have concerns regarding outstanding violations of...

more »FDA imposes import ban on certain Olympus medical devices from Japan

Heatstroke: Symptoms, risks, and the dangers of temperatures above 40 degrees Celsius in Germany

Extreme heat, especially temperatures above 40 degrees Celsius, poses a significant threat to human health. In Germany, where such heatwaves are becoming more frequent due to climate change, the risk of heat-related illnesses, including potentially fatal heatstroke, is increasing. This article examines the symptoms of heatstroke, the underlying pathophysiological mechanisms, risk factors, and the specific dangers in Germany, particularly at temperatures above 40 degrees. What is heatstroke? Heatstroke, often medically described as a consequence of heat hyperpyrexia (hyperthermia), occurs when the body loses its ability to thermoregulate and the core temperature rises to life-threatening levels (typically above 40°C). Without rapid intervention, this leads to multiple organ failure and death. Heatstroke is the most severe form of heat-related illness and differs from milder conditions like heat exhaustion due to its acute, systemic nature. Symptoms of heatstroke The symptoms of heatstroke, which can lead to death... 

more »Heatstroke: Symptoms, Risks, and the Dangers of Temperatures Above 40 Degrees in Germany

Winfried Stöcker: Vaccine Rebel or Big Pharma Victim?

  • News

In the spring of 2020, as the world was engulfed in the Corona pandemic, Lübeck-based physician and entrepreneur Winfried Stöcker began working on a vaccine against SARS-CoV-2 in his private laboratory. Stöcker, an experienced immunologist and founder of the diagnostics company Euroimmun, which he sold in 2017 for 1.2 billion euros, developed a protein-based antigen he named "LubecaVax." His approach was classic: a recombinant spike protein, produced in cell cultures, was intended to trigger antibody formation without using the novel mRNA technology from BioNTech or Moderna. Stöcker first tested the antigen on himself, later on family members and volunteers. Neutralization tests, including those by Christian Drosten at Charité, confirmed the formation of virus-neutralizing antibodies. Stöcker claimed his vaccine was safe, effective, and could be produced in large quantities – up to one million doses per day with a 2000-liter reactor. However, instead of recognition, he faced criminal charges, police raids, and media controversy. While BioNTech… 

more »Winfried Stöcker: Vaccine Rebel or Big Pharma Victim?

The Development of Euroimmun and the Legacy of its Founder: A Medical Retrospective

Euroimmun Medizinische Labordiagnostika AG, a leading company in medical diagnostics, has come a long way since its founding in 1987. Founded by Professor Dr. Winfried Stöcker in Lübeck, Euroimmun developed from a small start-up into a globally active group, now known for its innovative test systems for the diagnosis of autoimmune diseases, infectious diseases, and allergies. At the same time, Stöcker, a physician and entrepreneur, shaped the company and its culture, but also left his mark through controversial actions and statements that attracted attention beyond the scientific world. This article examines the development of Euroimmun, the role of its founder, and what has become of both, in an objective, medical context. Euroimmun's history began at a time when medical laboratory diagnostics was far less automated than it is today. Winfried Stöcker, born in 1947 in Rennersdorf in the Upper Lusatia region, studied medicine and then...

more »The Development of Euroimmun and its Founder's Legacy: A Medical Retrospective

Erosion of Democracy in German Laboratories: An Evidence-Based Analysis

Berlin, June 28, 2025 – In Germany, a country known for its stable democracy and scientific excellence, there are increasing signs of a worrying development: the erosion of democratic principles in scientific laboratories. This trend is evident in increasing control, restricted freedom of expression, precarious working conditions, and a shift in research autonomy. The consequences range from a threat to scientific integrity to a weakening of public trust in science. This report analyzes the causes, mechanisms, and effects of this development, highlights historical parallels, and examines the consequences for Germany and beyond. The analysis remains objective, value-free, and evidence-based in order to provide a nuanced picture. Introduction: Science as a Mirror of Society Scientific laboratories are more than just places of research; they are microcosms where societal values, power structures, and democratic principles are reflected. In Germany, where institutions such as the Max Planck Society, the Helmholtz Association…

more »Erosion of Democracy in German Laboratories: An Evidence-Based Analysis

Downfall of the German Biotech Industry? A Nuanced Perspective in International Comparison

  • News

Berlin, June 28, 2025 – The German biotechnology sector is the focus of critical debates: While it gained global attention during the Corona pandemic with mRNA vaccines, experts are now warning of an impending decline. The international comparison shows a mixed picture of strengths, untapped potential, and growing challenges. This report analyzes the industry's situation based on current data and compares it with global competitors. Growth with braking marks According to the BIOCOM company survey 2024, which recorded key figures for 2023, the German biotech industry recorded revenue growth despite economic stagnation. Excluding the pandemic-related decline at BioNTech, revenue increased from €8.1 billion (2022) to €8.75 billion (+8%). The number of dedicated biotech companies grew to 798, and the number of employees to 47,400 (+10%). Research and development (R&D) expenditures reached a record €3.74 billion (+12.2%), with BioNTech's oncology research (€1.78 billion) accounting for a large portion. Nevertheless, growth remains...

more »Downfall of the German Biotech Industry? A Differentiated View in International Comparison

Wave of insolvencies in the German healthcare system: Hospitals, practices, and pharmacies facing collapse

  • News

Berlin, June 28, 2025 – The German healthcare system is experiencing an unprecedented crisis: A wave of insolvencies is hitting hospitals, medical practices, pharmacies, and other facilities, endangering comprehensive care and posing existential challenges to the system. According to reports from gesundheitsmarkt.de, the German Hospital Association (DKG), and other sources, rising costs, lack of inflation compensation, shortage of skilled workers, and the absence of structural reforms have dramatically worsened the economic situation. Federal Health Minister Nina Waren is under pressure to find solutions as insolvencies increase. This article examines the causes, effects, and possible ways out of the crisis. The numbers: An alarming trend Insolvencies in the healthcare sector reached a peak in 2024, and the trend continues in 2025. According to gesundheitsmarkt.de, 14 hospitals with 21 locations filed for insolvency in 2024, along with 23 medical and dental practices with 69 locations, 23 pharmacies, and 11 dental laboratories. Further bankruptcies affected pharmaceutical companies, medical technology firms, as well as therapists and rehabilitation clinics. By May...

more »Wave of insolvencies in the German healthcare system: Hospitals, practices, and pharmacies facing collapse

Massacre in the Gaza Strip: Serious accusations against the IDF, international arrest warrant, and the question of Trump's responsibility

  • News

Gaza, June 28, 2025 – The latest revelations about a massacre by the Israel Defense Forces (IDF) in the Gaza Strip, in which soldiers allegedly received orders to shoot civilians indiscriminately, have caused horror worldwide. The Israeli daily Haaretz provided detailed reports shedding light on the systematic nature of these attacks. At the same time, Israeli Prime Minister Benjamin Netanyahu is under an arrest warrant from the International Criminal Court (ICC). Amidst this crisis, there is discussion about whether former US President Donald Trump's policies indirectly contributed to this escalation. This article examines the allegations, international pressure, and Trump's possible role. Haaretz Revelations: Orders to Attack Civilians A report published on June 27, 2025, by the Israeli daily Haaretz quotes IDF soldiers involved in operations near humanitarian aid distribution centers in the Gaza Strip. The soldiers describe receiving instructions to shoot unarmed civilians who...

more »Massacre in Gaza: Serious Allegations Against the IDF, International Arrest Warrant, and the Question of Trump's Responsibility